Global access to quality-assured medical products: the Oxford Statement and call to action
Authors:
- Paul N NewtonPNPaul N Newton
- Paul NewtonPNPaul Newton
- Victor AbiolaVAVictor Abiola
- Khadijah Ade-AboladeKAKhadijah Ade-Abolade
- Moji AdeyeyeMAMoji Adeyeye
- Aria AhmadAAAria Ahmad
- Tahani AhmedTATahani Ahmed
- Pablo Alcocer VeraPVPablo Alcocer Vera
- Marie AmsilliMAMarie Amsilli
- Marie AntignacMAMarie Antignac
Open Access
- 1 December 2019
- journal article
- editorial
- Published by Elsevier in The Lancet Global Health
- Vol. 7 (12) , e1609-e1611
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income CountriesJAMA Network Open, 2018
- Fighting fake medicines: First quality evaluation of cardiac drugs in AfricaInternational Journal of Cardiology, 2017
- An epidemic of dystonic reactions in central AfricaThe Lancet Global Health, 2017